Spotlight
Featured
Universities & pharma companies need each other to create world-changing medicines
Simon Goldman highlights the need of closer partnerships between pharma and universitites on Pharmaforum
Bloomsbury GTx announces publication of article highlighting preclinical data from BGT-NPC programme.
A potential new brain-targeted therapeutic for the treatment of Niemann-Pick Type C Disease (NPC).
Quell Therapeutics signs a $2bn plus deal with AstraZeneca | FT
UCLTF cell therapy startup Quell Therapeutics signs a $2bn plus deal with AstraZeneca | FT
Leigh Brody, UCLTF Investor | Career in Discovery Podcast
Leigh Brody, UCLTF investor on TalentSingular’s ‘Careers in discovery’ podcast
Orchard Therapeutics’ new life-saving gene therapy to treat MLD | BBC News
UCLTF’s company has developed a life-saving gene therapy drug now available on the NHS
Bloomsbury GTX launches with Seed financing of £5m to develop the promise of gene therapy